Last Updated: November 19, 2026

Details for Patent: 12,377,176

« Back to Dashboard


Which drugs does patent 12,377,176 protect, and when does it expire?

Patent 12,377,176 protects POSLUMA and is included in one NDA.

This patent has eighteen patent family members in twelve countries.

Summary for Patent: 12,377,176
Title:Cancer diagnostic imaging agents
Abstract:The present invention relates to a ligand-SIFA-chelator conjugate, comprising, within a single molecule three separate moieties: (a) one or more ligands which are capable of binding to PSMA, (b) a silicon-fluoride acceptor (SIFA) moiety which comprises a covalent bond between a silicon atom and a fluorine atom, and (c) one or more chelating groups, containing a chelated nonradioactive cation.
Inventor(s):Alexander Josef Wurzer, Hans-Jürgen Wester, Matthias Johannes Eiber
Assignee: Technische Universitaet Muenchen Klinikum Rechts Der Isar , Technische Universitaet Muenchen , Klinikum Rechts der Isar der Technischen Universitaet Muenchen
Application Number:US17/427,006
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 12,377,176

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Blue Earth POSLUMA flotufolastat f-18 gallium SOLUTION;INTRAVENOUS 216023-001 May 25, 2023 RX Yes Yes ⤷  Start Trial ⤷  Start Trial Y ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 12,377,176

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2020215086 ⤷  Start Trial
Australia 2023208070 ⤷  Start Trial
Brazil 112021015035 ⤷  Start Trial
Canada 3128406 ⤷  Start Trial
China 113573743 ⤷  Start Trial
China 116585494 ⤷  Start Trial
Eurasian Patent Organization 202192045 ⤷  Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.